Switch to:
More From Other Websites
Sanofi's diabetes drug Toujeo gets U.S. approval, label disappoints Feb 26 2015
Lilly Plans to Introduce Biosimilar Lantus in Europe Feb 26 2015
LILLY ELI & CO Financials Feb 26 2015
MannKind Reports Narrower Y/Y Loss in Q4, Afrezza in Focus - Analyst Blog Feb 25 2015
Lilly to Present at Cowen Health Care Conference Feb 24 2015
Bristol-Myers to Buy Flexus, Team Up with Rigel - Analyst Blog Feb 24 2015
Huge response to high-quality trades on busy issuance day Feb 24 2015
Eli Lilly's BIL Filing Delayed, Baricitinib Scores in Phase III - Analyst Blog Feb 24 2015
Lilly to Present at Cowen Health Care Conference Feb 24 2015
Eli Lilly and Company -- Moody's rates Eli Lilly's new notes A2; stable outlook Feb 24 2015
Eli Lilly stays out of deals fray as it eyes 'moon shot' drugs Feb 24 2015
Lilly long-acting insulin delayed by liver concerns Feb 23 2015
Lilly Delays Diabetes Treatment Submission Feb 23 2015
Lilly delays submission to market once-daily diabetes drug Feb 23 2015
Lilly Announces Update on Regulatory Submission Timing for Basal Insulin Peglispro Feb 23 2015
Lilly Announces Update on Regulatory Submission Timing for Basal Insulin Peglispro Feb 23 2015
Baricitinib Superior to Placebo in Reducing Rheumatoid Arthritis Disease Activity in Second Phase 3... Feb 23 2015
High Value But Little Glory: Innovating The Unmentionable Feb 22 2015
NASCAR Driver Ryan Reed Takes First Place At Daytona International Speedway Feb 21 2015
10-K for Eli Lilly & Co. Feb 21 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK